High-sensitivity C-reactive protein as an independent predictor of progressive myocardial functional deterioration: The multiethnic study of atherosclerosis

American Heart Journal

Volumn 164, Issue 2, 2012, Pages 251-258

  Choi, Eui Young ^a,b   Yan, Raymond T ^a   Fernandes, Veronica R S ^c   Opdahl, Anders ^a   Gomes, Antoinette S ^d   Almeida, Andre L C ^a   Wu, Colin O ^e   Liu, Kiang ^f   Carr, Jeffrey J ^g   McClelland, Robyn L ^h   Bluemke, David A ⁱ   Lima, Joao A C ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Yonsei University   (South Korea)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g WAKE FOREST UNIVERSITY   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; ETHNICITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE PROGRESSION; FEMALE; HEART; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 84864711817     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.05.010     Document Type: Article

References (20)

1. I.S. Anand, R. Latini, and V.G. Florea C-reactive protein in heart failure: prognostic value and the effect of valsartan Circulation 112 2005 1428 1434 (Pubitemid 41291768)
2. R.S. Vasan, L.M. Sullivan, and R. Roubenoff Framingham Heart Study. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study Circulation 107 2003 1486 1491 (Pubitemid 36378485)
3. H. Bahrami, D.A. Bluemke, and R. Kronmal Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) Study J Am Coll Cardiol 51 2008 1775 1783 (Pubitemid 351608497)
4. J.T. Willerson, and P.M. Ridker Inflammation as a cardiovascular risk factor Circulation 109 2004 II2 II10
5. B.D. Rosen, M. Cushman, and K. Nasir Relationship between C-reactive protein levels and regional left ventricular function in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis J Am Coll Cardiol 49 2007 594 600 (Pubitemid 46177433)
6. S.D. Prabhu Cytokine-induced modulation of cardiac function Circ Res 95 2004 1140 1153 (Pubitemid 39648205)
7. S.B. Yeon, N. Reichek, and B.A. Tallant Validation of in vivo myocardial strain measurement by magnetic resonance tagging with sonomicrometry J Am Coll Cardiol 38 2001 555 561 (Pubitemid 32721788)
8. D.E. Bild, D.A. Bluemke, and G.L. Burke Multi-ethnic study of atherosclerosis: objectives and design Am J Epidemiol 156 2002 871 881 (Pubitemid 35215769)
9. E. Castillo, N.F. Osman, and B.D. Rosen Quantitative assessment of regional myocardial function with MR-tagging in a multi-center study: interobserver and intraobserver agreement of fast strain analysis with Harmonic Phase (HARP) MRI J Cardiovasc Magn Reson 7 2005 783 791 (Pubitemid 41770056)
10. S. Natori, S. Lai, and J.P. Finn Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity AJR Am J Roentgenol 186 2006 S357 S365
11. J. Garot, D.A. Bluemke, and N.F. Osman Fast determination of regional myocardial strain fields from tagged cardiac images using harmonic phase MRI Circulation 101 2000 981 988 (Pubitemid 30131699)
12. V.R. Fernandes, J.F. Polak, and S. Cheng Arterial stiffness is associated with regional ventricular systolic and diastolic dysfunction: the Multi-Ethnic Study of Atherosclerosis Arterioscler Thromb Vasc Biol 28 2008 194 201
13. J.V. McMurray, T.A. McDonagh, and A.P. Davie Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure? Eur Heart J 19 1998 842 846 (Pubitemid 28269095)
14. E.G. Lakatta Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises, III: cellular and molecular clues to heart and arterial aging Circulation 107 2003 490 497 (Pubitemid 36158054)
15. J. Wang, D.S. Khoury, and Y. Yue Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure Eur Heart J 29 2008 1283 1289 (Pubitemid 351768130)
16. S. Cheng, V.R. Fernandes, and D.A. Bluemke Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis Circ Cardiovasc Imaging 2 2009 191 198
17. S. Verma, S.H. Li, and M.V. Badiwala Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein Circulation 105 2002 1890 1896 (Pubitemid 34437614)
18. E.S. Chung, M. Packer, and K.H. Lo Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure: results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial Circulation 107 2003 3133 3140 (Pubitemid 36793081)
19. J.J. McMurray, J. Kjekshus, L. Gullestad CORONA Study Group Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis Circulation 120 2009 2188 2196
20. T.W. Du Clos Function of C-reactive protein Ann Med 32 2000 274 278 (Pubitemid 30311864)